Literature DB >> 12752601

Enhancement of gelatinase activity during development of subepithelial fibrosis in a murine model of asthma.

M Corbel1, S Caulet-Maugendre, N Germain, V Lagente, E Boichot.   

Abstract

BACKGROUND: Chronic asthma is characterized by inflammatory cell infiltration and tissue remodelling leading to subepithelial fibrosis. Metalloproteinases (MMPs) are involved in degradation of extracellular matrix in most chronic inflammatory diseases.
OBJECTIVE: The aim of this study was to investigate the expression of MMPs in the development of inflammatory processes associated or not with the concomitant development of subepithelial fibrosis in an experimental model of asthma.
METHODS: Sensitized BP2 mice were challenged with ovalbumin (OA) every 2 weeks during 8 months. Several mice were removed once a month and bronchoalveolar lavages (BAL) or lung biopsies were performed.
RESULTS: Lung sections stained with picrosirius and hydroxyproline measurements showed a significant collagen deposition after 16 weeks of OA challenge, demonstrating the development of subepithelial fibrosis. Pulmonary inflammation was present from the first OA challenge and was consistent throughout the 8 months of the study. Moreover, an up-regulation and activation of MMP-9 and, to a less extent, MMP-2 were observed in BAL fluid from challenged mice. The level of tissue inhibitor of metalloproteinases (TIMP)-1 increased after 12 weeks of OA challenge vs. control mice.
CONCLUSION: This study reveals that a decrease in the activation of the MMP-9 due to the increase in TIMP-1, could contribute to excessive collagen deposition following repeated antigen challenge in sensitized mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752601     DOI: 10.1046/j.1365-2222.2003.01581.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.

Authors:  H Matsumoto; A Niimi; M Takemura; T Ueda; M Minakuchi; R Tabuena; K Chin; T Mio; Y Ito; S Muro; T Hirai; S Morita; S Fukuhara; M Mishima
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

2.  Adam8 limits the development of allergic airway inflammation in mice.

Authors:  Martin D Knolle; Takahiro Nakajima; Anja Hergrueter; Kushagra Gupta; Francesca Polverino; Vanessa J Craig; Susanne E Fyfe; Muhammad Zahid; Perdita Permaul; Manuela Cernadas; Gilbert Montano; Yohannes Tesfaigzi; Lynette Sholl; Lester Kobzik; Elliot Israel; Caroline A Owen
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

3.  Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial Asthma.

Authors:  Yoshinori Takahashi; Tetsu Kobayashi; Corina N D'Alessandro-Gabazza; Masaaki Toda; Kentaro Fujiwara; Tomohito Okano; Hajime Fujimoto; Kentaro Asayama; Atsuro Takeshita; Taro Yasuma; Kota Nishihama; Ryo Inoue; Liqiang Qin; Yoshiyuki Takei; Osamu Taguchi; Esteban C Gabazza
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

4.  Inflammatory and remodeling events in asthma with chronic exposure to house dust mites: a murine model.

Authors:  Joong Hyun Ahn; Chi Hong Kim; Yong Hyun Kim; Seung Joon Kim; Sook Young Lee; Young Kyoon Kim; Kwan Hyoung Kim; Hwa Sik Moon; Jeong Sup Song; Sung Hak Park; Soon Seog Kwon
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

5.  Reduced lung function in a chronic asthma model is associated with prolonged inflammation, but independent of peribronchial fibrosis.

Authors:  Cordula Koerner-Rettberg; Sandra Doths; Anke Stroet; Jürgen Schwarze
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

Review 6.  Controversy surrounding the increased expression of TGF beta 1 in asthma.

Authors:  Ynuk Bossé; Marek Rola-Pleszczynski
Journal:  Respir Res       Date:  2007-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.